Joint Arthritis Treatment
in Tulsa, Oklahoma

These are three distinct disease processes that can all damage joints. Osteoarthritis (OA) is a wear-and-tear loss of cartilage, typically in weight-bearing or heavily used joints, and is by far the most common form. Rheumatoid arthritis (RA) is a systemic autoimmune disease that inflames the joint lining (synovium) and, left untreated, erodes bone, it often affects small joints symmetrically and requires a rheumatologist for disease-modifying therapy. Post-traumatic arthritis develops after injury (fracture, ligament damage, meniscus tear) and behaves mechanically like OA but tends to appear earlier in life. Interventional pain management helps with the pain of all three, but the overall treatment strategy differs.

This is one of the most common concerns we hear. At appropriate doses and intervals, intra-articular corticosteroid injections are well-tolerated and widely considered safe. Concerns about cartilage harm arise mainly from frequent, repeated high-dose injections in the same joint, which is why most pain specialists limit injections in a single joint to a small number per year and space them appropriately. Dr. Bhakta's approach is conservative: steroid is used when it will materially help, and we rotate in other options like viscosupplementation or PRP to avoid over-reliance on any one tool.

They work differently. Corticosteroid calms inflammation quickly and can provide meaningful relief for weeks to months, particularly during a flare, but it doesn't change the underlying disease. PRP (platelet-rich plasma) uses concentrated growth factors from your own blood to modulate the joint environment and support tissue health, with benefits that tend to build gradually over weeks and often last six to twelve months or longer in mild-to-moderate osteoarthritis. Growing evidence suggests PRP may outperform steroid for longer-term outcomes in knee OA, though responses vary. Dr. Bhakta helps you weigh cost, speed of relief, and goals to pick the right option.

Viscosupplementation (injection of hyaluronic acid into the joint) works best in knee osteoarthritis (FDA-approved) and in carefully selected patients with hip, shoulder, or ankle OA. It is particularly useful when the joint feels 'dry,' stiff, and creaky, and often provides four to six months of meaningful relief. PRP is more versatile, can be used in a wider range of joints, and may offer benefits in both cartilage and surrounding tendon/ligament tissues. The two are not mutually exclusive, in some patients we sequence or combine them. Insurance coverage also influences the decision, and we help navigate that.

Yes, and it is more common than many people realize. Early cartilage changes, synovitis, subchondral bone edema, and soft-tissue drivers of joint pain can all exist before bone-level changes show on a plain X-ray. In these situations, MRI or point-of-care ultrasound often reveals findings that explain the symptoms. The flip side is also true: many older adults have significant X-ray arthritis with little or no pain. Dr. Bhakta treats the person and their symptoms, not the image alone.

There is no FDA-approved disease-modifying drug for osteoarthritis yet, but many factors that influence progression are modifiable: weight, muscle strength, mechanical alignment, and the level of ongoing inflammation inside the joint. Losing even a modest amount of weight has been shown to meaningfully reduce knee pain and slow functional decline. Regular low-impact activity, targeted strengthening, and well-timed injections to quiet inflammation can meaningfully change the long-term trajectory for many patients. The disease is not a fixed sentence, day-to-day choices matter, and Dr. Bhakta builds those into the plan.